CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

ZYMEZymeworks Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $26.49 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$1.88B
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-09 · Schayowitz Adam (EVP, Head of R&D) · SELL
  • 2026-10-09 · Schayowitz Adam (EVP, Head of R&D) · OTHER
  • 2026-07-06 · Hollywood Mark (EVP & Chief Operating Officer) · OTHER
  • 2026-01-13 · Hollywood Mark (EVP & Chief Operating Officer) · SELL
  • 2026-01-12 · Smith Jeffrey T L (EVP & Chief Medical Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders220
Shares held76,620,192
Value$1.91B
Percent of shares outstanding107.98%
As of quarter end2026-06-30
RECENT NEWS
  • Zymeworks EVP Adam Schayowitz sells $357,557 in ZYME stock for taxes
  • Zymeworks EVP, head of R&D Adam Schayowitz sells $357,557 in stock.
  • Zymeworks Inc. (ZYME) M&A Call Transcript
  • Zymeworks Inc. (ZYME) Theravance Biopharma, Inc. - M&A Call - Slideshow
  • Zymeworks updates 2026 guidance after Theravance Biopharma acquisition
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS